Shortcomings of PASI75 and practical calculation of PASI area component

Journal of the American Academy of Dermatology

Volumn 68, Issue 1, 2013, Pages 180-181

  Puig, Lluís ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BRIAKINUMAB; INFLIXIMAB; USTEKINUMAB;

BODY SURFACE; DISEASE SEVERITY; HUMAN; LETTER; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS SEVERITY INDEX 75; PSORIASIS SEVERITY INDEX 90; SCORING SYSTEM;

BIOLOGICAL AGENTS; DERMATOLOGY; HUMANS; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 84870903209     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.03.039     Document Type: Letter

References (5)

1. A. Robinson, M. Kardos, and A.B. Kimball Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis J Am Acad Dermatol 66 2012 369 375
2. L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, and J.M. Hernanz Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology [in Spanish] Actas Dermosifiliogr 100 2009 277 286
3. Psoriasis Area and Severity Index (PASI) training. Available from: URL: http://pasitraining.com/pasi-score/index.html. Accessed March 3, 2011.
4. C.C. Long, A.Y. Finlay, and R.W. Averill The rule of hand: 4 hand areas = 2 FTU = 1 g Arch Dermatol 128 1992 1129 1130
5. C.C. Jacobson, and A.B. Kimball Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased Br J Dermatol 151 2004 381 387